School of Nursing, University of Texas at Austin, Austin, TX, USA.
Department of Oncology, Dell Medical School, University of Texas at Austin, Austin, TX, USA.
J Natl Cancer Inst. 2021 Nov 29;113(12):1625-1633. doi: 10.1093/jnci/djab027.
Cancer and its treatments are associated with increased risk for cancer-related cognitive impairment (CRCI). Methods and measures used to study and assess self-reported CRCI (sr-CRCI), however, remain diverse, resulting in heterogeneity across studies. The Patient-Reported Outcomes Working Group has been formed to promote homogeneity in the methods used to study sr-CRCI. In this report, using a psychometric taxonomy, we inventory and appraise instruments used in research to measure sr-CRCI, and we consider advances in patient-reported outcome methodology. Given its psychometric properties, we recommend the Patient-Reported Outcome Measurement Information System Cognitive Function Short Form 8a for measurement of sr-CRCI in cancer patients and survivors, at a minimum, to increase scientific rigor and progress in addressing CRCI.
癌症及其治疗与癌症相关认知障碍（CRCI）的风险增加有关。然而，用于研究和评估自我报告的 CRCI（sr-CRCI）的方法和措施仍然多种多样，导致研究之间存在异质性。患者报告结果工作组已经成立，旨在促进用于研究 sr-CRCI 的方法的一致性。在本报告中，我们使用心理计量分类法，对用于研究 sr-CRCI 的工具进行了清查和评估，并考虑了患者报告结果方法学的进展。鉴于其心理计量特性，我们建议在癌症患者和幸存者中至少使用患者报告结果测量信息系统认知功能简短形式 8a 来测量 sr-CRCI，以提高科学严谨性并在解决 CRCI 方面取得进展。
